Prevalence and genetic characteristics of norovirus epidemics in Guangdong province, 2021
-
摘要:
目的 分析2021年广东省诺如病毒聚集性或暴发疫情的流行病学特征。 方法 收集广东省2021年1 — 12月诺如病毒感染疫情样本及相关基本信息,通过实时荧光定量PCR(qRT-PCR)对样本进行诺如病毒的鉴定,筛选诺如病毒GI型和GII型阳性样本,通过PCR扩增、建库、测序、序列拼接后对其进行基因分型。 结果 2021年广东省共报告141起诺如病毒感染疫情,其中92.91 %(131起)的疫情发生在托幼机构或学校;疫情的流行季节为冬春季。73起疫情(51.77 %)确定了基因分型。94.52 %(133起)的诺如病毒感染疫情由GII型引起,其中GII.2[P16]和GII.4[P31]分别占比39.13 % 和23.19 %。 结论 广东省2021年诺如病毒疫情主要发生在托幼机构和学校,GII.2[P16]和GII.4[P31]分别是春季和冬季的主要流行型别,仍需继续加强诺如病毒疫情监测以及分子分型研究。 Abstract:Objective To analyze prevalence and genetic characteristics of clusterings/outbreaks of norovirus (NV) infection in Guangdong province in 2021. Methods We collected the information on all laboratory confirmed NV infection clusterings (3 correlated cases in 3 days at a venue) and outbreaks (20 correlated cases in 7 days at a venue) reported in Guangdong province throughout 2021. Anal swab/stool specimens of the reported cases were sampled for NV detection with quantitative real-time PCR (qRT-PCR). The NV GI and GII strains screened out from positive specimens were genotyped with PCR amplification, library preparation, gene sequencing and splicing. Results Of a total of 141 NV clusterings/outbreaks reported in the province during the year, 92.91% occurred in nurseries or schools and mainly during winter and spring seasons. For the genotyped NV strains isolated from specimens of 73 outbreaks (51.77% of all epidemics), 94.52% were NV GII, with GII.2[P16] and GII.4[P31] accounting for 39.13% and 23.19% of all NV strains, respectively. Conclusion In Guangdong province during 2021, the norovirus clusterings/outbreaks occurred mainly in nurseries and schools in winter/spring seasons and the majority of the outbreaks were caused by norovirus GII.2[P16] and GII.4[P31]. -
Key words:
- norovirus /
- epidemic /
- genotype /
- epidemiological characteristics
-
表 1 2021年广东省NV疫情发生场所与NV基因型分布
基因型 疫情发生场所(起) 合计 托幼机构 中小学 职业技术学院 大学 集体单位 社区及家庭 酒店 GII.2[P16] 10 15 0 0 2 0 0 27 GII.3[P12] 1 2 1 0 0 0 0 4 GII.4[P16] 2 0 0 0 1 0 0 3 GII.17[P17] 2 7 1 0 1 0 1 12 GII.8[P8] 1 1 0 0 0 0 0 2 GII.6[P7] 1 3 0 1 0 0 0 5 GII.4[P31] 14 1 0 1 0 0 0 16 GI.6[P11] 0 1 1 0 0 0 0 2 GI.4[P4] 0 1 0 0 0 0 0 1 混合基因型 0 0 0 1 0 0 0 1 未知基因型 30 28 2 3 3 2 0 68 合计 61 59 5 6 7 2 1 141 -
[1] Fumian TM, Fioretti JM, Lun JH, et al. Detection of norovirus epidemic genotypes in raw sewage using next generation sequenc-ing[J]. Environment International, 2019, 123: 282 – 291. doi: 10.1016/j.envint.2018.11.054 [2] Jin M, Wu SY, Kong XY, et al. Norovirus outbreak surveillance, China, 2016 – 2018[J]. Emerging Infectious Diseases, 2020, 26(3): 437 – 445. doi: 10.3201/eid2603.191183 [3] Robilotti E, Deresinski S, Pinsky BA. Norovirus[J]. Clinical Microbiology Reviews, 2015, 28(1): 134 – 164. doi: 10.1128/CMR.00075-14 [4] Chhabra P, de Graaf M, Parra GI, et al. Updated classification of norovirus genogroups and genotypes[J]. Journal of General Virology, 2019, 100(10): 1393 – 1406. doi: 10.1099/jgv.0.001318 [5] Ao YY, Wang JJ, Ling H, et al. Norovirus GII. P16/GII. 2-associated gastroenteritis, China, 2016[J]. Emerging Infectious Diseases, 2017, 23(7): 1172 – 1175. doi: 10.3201/eid2307.170034 [6] 廖巧红, 冉陆, 靳森, 等. 诺如病毒感染暴发调查和预防控制技术指南(2015版)[J]. 中华预防医学杂志, 2016, 50(1): 7 – 16. doi: 10.3760/cma.j.issn.0253-9624.2016.01.003 [7] 张萌, 龙遗芳, 郭莉敏, 等. 广东省2013 — 2017年3种基因型诺如病毒感染暴发疫情的流行特征[J]. 中华流行病学杂志, 2018, 39(9): 1210 – 1215. doi: 10.3760/cma.j.issn.0254-6450.2018.09.013 [8] 苏文哲, 耿进妹, 赖赛麟, 等. 诺如病毒重组株GII. P16 – GII. 2在广州地区引起暴发的分子流行病学调查[J]. 中华实验和临床病毒学杂志, 2019, 33(4): 362 – 368. doi: 10.3760/cma.j.issn.1003-9279.2019.04.006 [9] Grant LR, O′Brien KL, Weatherholtz RC, et al. Norovirus and sapovirus epidemiology and strain characteristics among Navajo and Apache infants[J]. PLoS One, 2017, 12(1): e0169491. doi: 10.1371/journal.pone.0169491 [10] Bruggink LD, Garcia-Clapes A, Tran T, et al. Decreased incidence of enterovirus and norovirus infections during the COVID-19 pandemic, Victoria, Australia, 2020[J]. Communicable Diseases Intelligence (2018), 2021: 45. doi: 10.33321/cdi.2021.45.5. [11] Nachamkin I, Richard-Greenblatt M, Yu M, et al. Reduction in sporadic norovirus infections following the start of the COVID-19 pandemic, 2019 – 2020, Philadelphia[J]. Infectious Diseases and Therapy, 2021, 10(3): 1793 – 1798. doi: 10.1007/s40121-021-00473-z [12] O′Reilly KM, Sandman F, Allen D, et al. Predicted norovirus resur-gence in 2021 – 2022 due to the relaxation of nonpharmaceutical interventions associated with COVID-19 restrictions in England: a mathematical modeling study[J]. BMC Medicine, 2021, 19(1): 299. doi: 10.1186/s12916-021-02153-8 [13] Steele MK, Wikswo ME, Hall AJ, et al. Characterizing norovirus transmission from outbreak data, United States[J]. Emerging Infectious Diseases, 2020, 26(8): 1818 – 1825. doi: 10.3201/eid2608.191537 [14] Hasing ME, Lee BE, Qiu YY, et al. Changes in norovirus genotype diversity in gastroenteritis outbreaks in Alberta, Canada: 2012 – 2018[J]. BMC Infectious Diseases, 2019, 19(1): 177. doi: 10.1186/s12879-019-3792-y [15] Wei N, Ge J, Tan CY, et al. Epidemiology and evolution of Norovirus in China[J]. Human Vaccines and Immunotherapeutics, 2021, 17(11): 4553 – 4566. doi: 10.1080/21645515.2021.1961465 [16] Fang XY, Ai J, Liu WD, et al. Epidemiology of infectious diarrhoea and the relationship with etiological and meteorological factors in Jiangsu province, China[J]. Scientific Reports, 2019, 9(1): 19571. doi: 10.1038/s41598-019-56207-2 [17] Liu LTC, Kuo TY, Wu CY, et al. Recombinant GII. P16-GII.2 norovirus, Taiwan, 2016[J]. Emerging Infectious Diseases, 2017, 23(7): 1180 – 1183. doi: 10.3201/eid2307.170212 [18] Geng Q, Shen Y, Shi P, et al. Epidemiologic features and influencing factors of norovirus outbreaks in the city of Wuxi, China from 2014 to 2018[J]. The American Journal of Tropical Medicine and Hygiene, 2021, 105(6): 1575 – 1581. doi: 10.4269/ajtmh.20-1371 [19] Han JK, Ji L, Shen YH, et al. Emergence and predominance of norovirus GII. 17 in Huzhou, China, 2014 – 2015[J]. Virology Journal, 2015, 12: 139. doi: 10.1186/s12985-015-0370-9 [20] Wang J, Jin M, Zhang HL, et al. Norovirus GII.2[P16] strain in Shenzhen, China: a retrospective study[J]. BMC Infectious Diseases, 2021, 21(1): 1122. doi: 10.1186/s12879-021-06746-9 [21] Zhu X, He YQ, Wei XY, et al. Molecular epidemiological characteristics of gastroenteritis outbreaks caused by norovirus GII.4 sydney [P31] strains – China, October 2016 – December 2020[J]. China CDC Weekly, 2021, 3(53): 1127 – 1132. doi: 10.46234/ccdcw2021.276 [22] Wang H, Wang DH, Chen C, et al. Epidemiologic characteristics of outbreaks of three norovirus genotypes (GII.2, GII.17 and GII.4 Sydney) in Guangzhou, China, from 2012 to 2018[J]. Epidemiology and Infection, 2019, 147: e207. doi: 10.1017/S0950268819000992 -